BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35422697)

  • 1. Development and Co-design of NeuroOrb: A Novel "Serious Gaming" System Targeting Cognitive Impairment in Parkinson's Disease.
    Guglietti B; Hobbs DA; Wesson B; Ellul B; McNamara A; Drum S; Collins-Praino LE
    Front Aging Neurosci; 2022; 14():728212. PubMed ID: 35422697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Cognitive Training for the Treatment of Cognitive Dysfunction in Parkinson's Disease: Current Limitations and Future Directions.
    Guglietti B; Hobbs D; Collins-Praino LE
    Front Aging Neurosci; 2021; 13():709484. PubMed ID: 34720988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of virtual rehabilitation versus conventional physical therapy on postural control, gait, and cognition of patients with Parkinson's disease: study protocol for a randomized controlled feasibility trial.
    Silva KG; De Freitas TB; Doná F; Ganança FF; Ferraz HB; Torriani-Pasin C; Pompeu JE
    Pilot Feasibility Stud; 2017; 3():68. PubMed ID: 29225912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Parkin'Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson's disease.
    van de Weijer SC; Duits AA; Bloem BR; Kessels RP; Jansen JF; Köhler S; Tissingh G; Kuijf ML
    BMC Neurol; 2016 Nov; 16(1):209. PubMed ID: 27809791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.
    van Balkom TD; Berendse HW; van der Werf YD; Twisk JWR; Zijlstra I; Hagen RH; Berk T; Vriend C; van den Heuvel OA
    BMC Neurol; 2019 Jul; 19(1):179. PubMed ID: 31366395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.
    Leta V; Urso D; Batzu L; Weintraub D; Titova N; Aarsland D; Martinez-Martin P; Borghammer P; van Wamelen DJ; Yousaf T; Rizos A; Rodriguez-Blazquez C; Chung-Faye G; Chaudhuri KR
    J Parkinsons Dis; 2021; 11(3):1209-1219. PubMed ID: 33843697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assistive HCI-Serious Games Co-design Insights: The Case Study of i-PROGNOSIS Personalized Game Suite for Parkinson's Disease.
    Dias SB; Diniz JA; Konstantinidis E; Savvidis T; Zilidou V; Bamidis PD; Grammatikopoulou A; Dimitropoulos K; Grammalidis N; Jaeger H; Stadtschnitzer M; Silva H; Telo G; Ioakeimidis I; Ntakakis G; Karayiannis F; Huchet E; Hoermann V; Filis K; Theodoropoulou E; Lyberopoulos G; Kyritsis K; Papadopoulos A; Depoulos A; Trivedi D; Chaudhuri RK; Klingelhoefer L; Reichmann H; Bostantzopoulou S; Katsarou Z; Iakovakis D; Hadjidimitriou S; Charisis V; Apostolidis G; Hadjileontiadis LJ
    Front Psychol; 2020; 11():612835. PubMed ID: 33519632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.
    Simon-Gozalbo A; Rodriguez-Blazquez C; Forjaz MJ; Martinez-Martin P
    Front Neurol; 2020; 11():731. PubMed ID: 32849203
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; Pilati L; Restivo V; Zappia M; Monastero R
    Front Aging Neurosci; 2019; 11():21. PubMed ID: 30800065
    [No Abstract]   [Full Text] [Related]  

  • 13. Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.
    Lawson RA; Yarnall AJ; Duncan GW; Khoo TK; Breen DP; Barker RA; Collerton D; Taylor JP; Burn DJ
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1071-5. PubMed ID: 25074728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease.
    Macaskill MR; Graham CF; Pitcher TL; Myall DJ; Livingston L; van Stockum S; Dalrymple-Alford JC; Anderson TJ
    Neuropsychologia; 2012 Dec; 50(14):3338-47. PubMed ID: 23000134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease.
    Schneider JS; Marshall CA; Keibel L; Snyder NW; Hill MP; Brotchie JM; Johnston TH; Waterhouse BD; Kortagere S
    Exp Neurol; 2021 Jan; 335():113514. PubMed ID: 33141071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Training in Parkinson's Disease.
    Walton CC; Naismith SL; Lampit A; Mowszowski L; Lewis SJ
    Neurorehabil Neural Repair; 2017 Mar; 31(3):207-216. PubMed ID: 27899737
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.